U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from PMC

Familial prostate cancer

MedGen UID:
419810
Concept ID:
C2931456
Neoplastic Process
Synonym: Hereditary prostate cancer
SNOMED CT: Familial malignant neoplasm of prostate (715412008); Familial prostate cancer (715412008)
Modes of inheritance:
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
Monarch Initiative: MONDO:0700275
OMIM®: 176807
Orphanet: ORPHA1331

Definition

Some cancerous tumors can invade surrounding tissue and spread to other parts of the body. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers. The signs and symptoms of metastatic cancer depend on where the disease has spread. If prostate cancer spreads, cancerous cells most often appear in the lymph nodes, bones, lungs, liver, or brain.

The severity and outcome of prostate cancer varies widely. Early-stage prostate cancer can usually be treated successfully, and some older men have prostate tumors that grow so slowly that they may never cause health problems during their lifetime, even without treatment. In other men, however, the cancer is much more aggressive; in these cases, prostate cancer can be life-threatening.

A small percentage of prostate cancers are hereditary and occur in families. These hereditary cancers are associated with inherited gene variants. Hereditary prostate cancers tend to develop earlier in life than non-inherited (sporadic) cases.

Early prostate cancer usually does not cause pain, and most affected men exhibit no noticeable symptoms. Men are often diagnosed as the result of health screenings, such as a blood test for a substance called prostate specific antigen (PSA) or a medical exam called a digital rectal exam (DRE). As the tumor grows larger, signs and symptoms can include difficulty starting or stopping the flow of urine, a feeling of not being able to empty the bladder completely, blood in the urine or semen, or pain with ejaculation. However, these changes can also occur with many other genitourinary conditions. Having one or more of these symptoms does not necessarily mean that a man has prostate cancer.

Prostate cancer is a common disease that affects men, usually in middle age or later. In this disorder, certain cells in the prostate become abnormal, multiply without control or order, and form a tumor. The prostate is a gland that surrounds the male urethra and helps produce semen, the fluid that carries sperm. [from MedlinePlus Genetics]

Clinical features

From HPO
Malignant tumor of prostate
MedGen UID:
138169
Concept ID:
C0376358
Neoplastic Process
A cancer of the prostate.

Professional guidelines

PubMed

Bakavicius A, Marra G, Macek P, Robertson C, Abreu AL, George AK, Malavaud B, Coloby P, Rischmann P, Moschini M, Rastinehad AR, Sidana A, Stabile A, Tourinho-Barbosa R, de la Rosette J, Ahmed H, Polascik T, Cathelineau X, Sanchez-Salas R
Int Braz J Urol 2022 Mar-Apr;48(2):263-274. doi: 10.1590/S1677-5538.IBJU.2021.0091. PMID: 34003610Free PMC Article
Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schutz FA, Kater FR, Pereira FMT, Monteiro FSM, Morbeck IAP, Reolon JFN, da Trindade KM, Andrade LMQDS, Nogueira LM, Furoni R, Natel RA, Dos Reis RB, Fogace RN, Souza VC
Int Braz J Urol 2021 Mar-Apr;47(2):359-373. doi: 10.1590/S1677-5538.IBJU.2020.0249. PMID: 33284538Free PMC Article
Kirby R
Practitioner 2014 Apr;258(1770):15-8, 2. PMID: 24881167

Curated

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Prostate Cancer, 2024

UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021

Suggested Reading

Recent clinical studies

Etiology

Mondschein R, Taylor R, Thorne H, Bolton D
Curr Opin Urol 2022 Sep 1;32(5):456-461. Epub 2022 Jul 18 doi: 10.1097/MOU.0000000000001024. PMID: 35855555
Boonen RACM, Wiegant WW, Celosse N, Vroling B, Heijl S, Kote-Jarai Z, Mijuskovic M, Cristea S, Solleveld-Westerink N, van Wezel T, Beerenwinkel N, Eeles R, Devilee P, Vreeswijk MPG, Marra G, van Attikum H
Cancer Res 2022 Feb 15;82(4):615-631. doi: 10.1158/0008-5472.CAN-21-1845. PMID: 34903604Free PMC Article
Ni Raghallaigh H, Eeles R
Fam Cancer 2022 Jan;21(1):101-114. Epub 2021 Jan 24 doi: 10.1007/s10689-021-00227-3. PMID: 33486571Free PMC Article
Giri VN, Beebe-Dimmer JL
Semin Oncol 2016 Oct;43(5):560-565. Epub 2016 Aug 18 doi: 10.1053/j.seminoncol.2016.08.001. PMID: 27899188Free PMC Article
Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS
Lancet 2016 Jan 2;387(10013):70-82. Epub 2015 Jun 11 doi: 10.1016/S0140-6736(14)61947-4. PMID: 26074382

Diagnosis

Mondschein R, Taylor R, Thorne H, Bolton D
Curr Opin Urol 2022 Sep 1;32(5):456-461. Epub 2022 Jul 18 doi: 10.1097/MOU.0000000000001024. PMID: 35855555
Alanazi IO, Alamery SF, Ebrahimie E, Mohammadi-Dehcheshmeh M
Mol Biol Rep 2022 Jun;49(6):4237-4246. Epub 2022 Mar 14 doi: 10.1007/s11033-022-07257-9. PMID: 35286517Free PMC Article
Ni Raghallaigh H, Eeles R
Fam Cancer 2022 Jan;21(1):101-114. Epub 2021 Jan 24 doi: 10.1007/s10689-021-00227-3. PMID: 33486571Free PMC Article
Giri VN, Beebe-Dimmer JL
Semin Oncol 2016 Oct;43(5):560-565. Epub 2016 Aug 18 doi: 10.1053/j.seminoncol.2016.08.001. PMID: 27899188Free PMC Article
Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS
Lancet 2016 Jan 2;387(10013):70-82. Epub 2015 Jun 11 doi: 10.1016/S0140-6736(14)61947-4. PMID: 26074382

Therapy

Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS
Lancet 2016 Jan 2;387(10013):70-82. Epub 2015 Jun 11 doi: 10.1016/S0140-6736(14)61947-4. PMID: 26074382
Bambury RM, Gallagher DJ
BJU Int 2012 Dec;110(11 Pt C):E809-18. Epub 2012 Sep 14 doi: 10.1111/j.1464-410X.2012.11450.x. PMID: 22974436
Pakkanen S, Kujala PM, Ha N, Matikainen MP, Schleutker J, Tammela TL
BJU Int 2012 Feb;109(4):557-63. Epub 2011 Apr 20 doi: 10.1111/j.1464-410X.2011.10198.x. PMID: 21507186
Wigle DT, Turner MC, Gomes J, Parent ME
J Toxicol Environ Health B Crit Rev 2008 Mar;11(3-4):242-59. doi: 10.1080/10937400701873548. PMID: 18368555
Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB
J Urol 2004 Nov;172(5 Pt 2):S6-11; discussion S11-2. doi: 10.1097/01.ju.0000142058.99614.ff. PMID: 15535435

Prognosis

Alanazi IO, Alamery SF, Ebrahimie E, Mohammadi-Dehcheshmeh M
Mol Biol Rep 2022 Jun;49(6):4237-4246. Epub 2022 Mar 14 doi: 10.1007/s11033-022-07257-9. PMID: 35286517Free PMC Article
Lassmann I, Dinkel A, Marten-Mittag B, Jahnen M, Schulwitz H, Gschwend JE, Herkommer K
Support Care Cancer 2021 Aug;29(8):4451-4460. Epub 2021 Jan 15 doi: 10.1007/s00520-020-05971-3. PMID: 33447865Free PMC Article
Giri VN, Beebe-Dimmer JL
Semin Oncol 2016 Oct;43(5):560-565. Epub 2016 Aug 18 doi: 10.1053/j.seminoncol.2016.08.001. PMID: 27899188Free PMC Article
Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS
Lancet 2016 Jan 2;387(10013):70-82. Epub 2015 Jun 11 doi: 10.1016/S0140-6736(14)61947-4. PMID: 26074382
Hemminki K
World J Urol 2012 Apr;30(2):143-8. Epub 2011 Nov 25 doi: 10.1007/s00345-011-0801-1. PMID: 22116601

Clinical prediction guides

Alanazi IO, Alamery SF, Ebrahimie E, Mohammadi-Dehcheshmeh M
Mol Biol Rep 2022 Jun;49(6):4237-4246. Epub 2022 Mar 14 doi: 10.1007/s11033-022-07257-9. PMID: 35286517Free PMC Article
Ni Raghallaigh H, Eeles R
Fam Cancer 2022 Jan;21(1):101-114. Epub 2021 Jan 24 doi: 10.1007/s10689-021-00227-3. PMID: 33486571Free PMC Article
Kim M, Kim JK, Ye C, Lee H, Oh JJ, Lee S, Jeong SJ, Lee SE, Hong SK, Byun SS
Prostate 2020 Jan;80(1):57-64. Epub 2019 Oct 30 doi: 10.1002/pros.23917. PMID: 31664733
Giri VN, Beebe-Dimmer JL
Semin Oncol 2016 Oct;43(5):560-565. Epub 2016 Aug 18 doi: 10.1053/j.seminoncol.2016.08.001. PMID: 27899188Free PMC Article
Attard G, Parker C, Eeles RA, Schröder F, Tomlins SA, Tannock I, Drake CG, de Bono JS
Lancet 2016 Jan 2;387(10013):70-82. Epub 2015 Jun 11 doi: 10.1016/S0140-6736(14)61947-4. PMID: 26074382

Recent systematic reviews

Johns LE, Houlston RS
BJU Int 2003 Jun;91(9):789-94. doi: 10.1046/j.1464-410x.2003.04232.x. PMID: 12780833

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2024
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Prostate Cancer, 2024
    • NICE, 2021
      UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...